Past two years | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 204 | 116 | 9 |
Full Text Views | 2 | 0 | 0 |
PDF Downloads | 0 | 0 | 0 |
We describe an in vitro microtest which is quantitative, rapid, and readily applicable to parasites isolated from all major forms of human leishmaniasis. It is based on drug-mediated inhibition of promastigote catabolism of a battery of simple 14C-substrates to 14CO2. Each test requires < 1µCi. The test is conducted in a serum-free, chemically defined medium containing 120 µg protein/ml, minimizing the possible interference of drug: serum protein interaction. Prior adaptation is not necessary to cultivate “difficult-to-grow” species. Leishmania sensitivity to pentavalent antimonials is detectable at µg levels below concentrations achievable in patients' sera.